Cause-Specific Excess Mortality in Siblings of Patients Co-Infected with HIV and Hepatitis C Virus
Open Access
- 15 August 2007
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 2 (8) , e738
- https://doi.org/10.1371/journal.pone.0000738
Abstract
Co-infection with hepatitis C in HIV-infected individuals is associated with 3- to 4-fold higher mortality among these patients' siblings, compared with siblings of mono-infected HIV-patients or population controls. This indicates that risk factors shared by family members partially account for the excess mortality of HIV/HCV-co-infected patients. We aimed to explore the causes of death contributing to the excess sibling mortality. We retrieved causes of death from the Danish National Registry of Deaths and estimated cause-specific excess mortality rates (EMR) for siblings of HIV/HCV-co-infected individuals (n = 436) and siblings of HIV mono-infected individuals (n = 1837) compared with siblings of population controls (n = 281,221). Siblings of HIV/HCV-co-infected individuals had an all-cause EMR of 3.03 (95% CI, 1.56–4.50) per 1,000 person-years, compared with siblings of matched population controls. Substance abuse-related deaths contributed most to the elevated mortality among siblings [EMR = 2.25 (1.09–3.40)] followed by unnatural deaths [EMR = 0.67 (−0.05–1.39)]. No siblings of HIV/HCV co-infected patients had a liver-related diagnosis as underlying cause of death. Siblings of HIV-mono-infected individuals had an all-cause EMR of 0.60 (0.16–1.05) compared with siblings of controls. This modest excess mortality was due to deaths from an unknown cause [EMR = 0.28 (0.07–0.48)], deaths from substance abuse [EMR = 0.19 (−0.04–0.43)], and unnatural deaths [EMR = 0.18 (−0.06–0.42)]. HCV co-infection among HIV-infected patients was a strong marker for family-related mortality due to substance abuse and other unnatural causes. To reduce morbidity and mortality in HIV/HCV-co-infected patients, the advances in antiviral treatment of HCV should be accompanied by continued focus on interventions targeted at substance abuse-related risk factors.Keywords
This publication has 18 references indexed in Scilit:
- Mortality in Siblings of Patients Coinfected with HIV and Hepatitis C VirusThe Journal of Infectious Diseases, 2007
- Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage studyThe Lancet, 2006
- Impact of Hepatitis C Virus Coinfection on Response to Highly Active Antiretroviral Therapy and Outcome in HIV-Infected Individuals: A Nationwide Cohort StudyClinical Infectious Diseases, 2006
- Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapyAIDS, 2006
- Impact of Hepatitis C Virus on Immune Restoration in HIV-Infected Patients Who Start Highly Active Antiretroviral Therapy: A Meta-analysisClinical Infectious Diseases, 2005
- Role of Hepatitis C Virus (HCV) Viremia and HCV Genotype in the Immune Recovery from Highly Active Antiretroviral Therapy in a Cohort of Antiretroviral-Naive HIV-Infected IndividualsClinical Infectious Diseases, 2005
- Demographics of HIV-1 infection in Denmark: Results from the Danish HIV Cohort StudyScandinavian Journal of Infectious Diseases, 2005
- Specificity of Genetic and Environmental Risk Factors for Use and Abuse/Dependence of Cannabis, Cocaine, Hallucinogens, Sedatives, Stimulants, and Opiates in Male TwinsAmerican Journal of Psychiatry, 2003
- Adoption Study Demonstrating Two Genetic Pathways to Drug AbuseArchives of General Psychiatry, 1995
- Undetected drug addict fatalitiesForensic Science International, 1993